Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen R Kelly

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|August 7, 2015
Racial Differences in Clostridium difficile Infection Rates Are Attributable to Disparities in Health Care AccessEric J Mao, Colleen R Kelly, Jason T Machan
Journal of Crohn'S & Colitis|March 11, 2019
Enterotoxigenic Clostridium perfringens Infection as an Adverse Event After Faecal Microbiota Transplantation in Two Patients With Ulcerative Colitis and Recurrent Clostridium difficile Infection: A Neglected Agent in Donor ScreeningMasoumeh Azimirad, Abbas Yadegar, Hamid Asadzadeh Aghdaei, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2019
Patients Eligible for Trials of Microbe-Based Therapeutics Do Not Represent the Population With Recurrent Clostridioides difficile InfectionColleen R Kelly, Monika Fischer, Ari Grinspan, et al.
Journal of Clinical Gastroenterology|November 14, 2015
A High Rate of Alternative Diagnoses in Patients Referred for Presumed Clostridium difficile InfectionMelissa Jackson, Sidney Olefson, Jason T Machan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 15, 2013
Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infectionLauren M De Leon, James B Watson, Colleen R Kelly
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 1, 2018
Nuts and Bolts of Fecal Microbiota TransplantationEdward Krajicek, Monika Fischer, Jessica R Allegretti, et al.
Gastroenterology|February 2, 2017
The AGA's Fecal Microbiota Transplantation National Registry: An Important Step Toward Understanding Risks and Benefits of Microbiota TherapeuticsColleen R Kelly, Alison M Kim, Loren Laine, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 1, 2026
AGA Clinical Practice Update on Management of Clostridioides difficile Infection in Adults: Expert ReviewMonika Fischer, Byron P Vaughn, Anne F Peery, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2021
Management of Severe and Severe/Complicated Clostridoides difficile Infection Using Sequential Fecal Microbiota Transplant by Retention EnemaAbbas Hatim Rupawala, Darrel Gachette, Mena Bakhit, et al.
Biologics : Targets & Therapy|August 27, 2025
What's New and What's Next in Fecal Microbiota Transplantation?Hussein Baydoun, Naushair Hussain, Ken O Wu, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|August 7, 2015
Racial Differences in Clostridium difficile Infection Rates Are Attributable to Disparities in Health Care AccessEric J Mao, Colleen R Kelly, Jason T Machan
Journal of Crohn'S & Colitis|March 11, 2019
Enterotoxigenic Clostridium perfringens Infection as an Adverse Event After Faecal Microbiota Transplantation in Two Patients With Ulcerative Colitis and Recurrent Clostridium difficile Infection: A Neglected Agent in Donor ScreeningMasoumeh Azimirad, Abbas Yadegar, Hamid Asadzadeh Aghdaei, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2019
Patients Eligible for Trials of Microbe-Based Therapeutics Do Not Represent the Population With Recurrent Clostridioides difficile InfectionColleen R Kelly, Monika Fischer, Ari Grinspan, et al.
Journal of Clinical Gastroenterology|November 14, 2015
A High Rate of Alternative Diagnoses in Patients Referred for Presumed Clostridium difficile InfectionMelissa Jackson, Sidney Olefson, Jason T Machan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 15, 2013
Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infectionLauren M De Leon, James B Watson, Colleen R Kelly
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 1, 2018
Nuts and Bolts of Fecal Microbiota TransplantationEdward Krajicek, Monika Fischer, Jessica R Allegretti, et al.
Gastroenterology|February 2, 2017
The AGA's Fecal Microbiota Transplantation National Registry: An Important Step Toward Understanding Risks and Benefits of Microbiota TherapeuticsColleen R Kelly, Alison M Kim, Loren Laine, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 1, 2026
AGA Clinical Practice Update on Management of Clostridioides difficile Infection in Adults: Expert ReviewMonika Fischer, Byron P Vaughn, Anne F Peery, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2021
Management of Severe and Severe/Complicated Clostridoides difficile Infection Using Sequential Fecal Microbiota Transplant by Retention EnemaAbbas Hatim Rupawala, Darrel Gachette, Mena Bakhit, et al.
Biologics : Targets & Therapy|August 27, 2025
What's New and What's Next in Fecal Microbiota Transplantation?Hussein Baydoun, Naushair Hussain, Ken O Wu, et al.
Pageof 9